Marino A P M P, Silva A A, Pinho R T, Lannes-Vieira J
Laboratório de Autoimunidade e Imuno-regulação, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brasil.
Braz J Med Biol Res. 2003 Aug;36(8):1121-33. doi: 10.1590/s0100-879x2003000800020. Epub 2003 Jul 23.
Several lines of evidence have shown that Trypanosoma cruzi interacts with host extracellular matrix (ECM) components producing breakdown products that play an important role in parasite mobilization and infectivity. Parasite-released antigens also modulate ECM expression that could participate in cell-cell and/or cell-parasite interactions. Increased expression of ECM components has been described in the cardiac tissue of chronic chagasic patients and diverse target tissues including heart, thymus, central nervous system and skeletal muscle of experimentally T. cruzi-infected mice. ECM components may adsorb parasite antigens and cytokines that could contribute to the establishment and perpetuation of inflammation. Furthermore, T. cruzi-infected mammalian cells produce cytokines and chemokines that not only participate in the control of parasitism but also contribute to the establishment of chronic inflammatory lesions in several target tissues and most frequently lead to severe myocarditis. T. cruzi-driven cytokines and chemokines may also modulate VCAM-1 and ICAM-1 adhesion molecules on endothelial cells of target tissues and play a key role in cell recruitment, especially of activated VLA-4+LFA-1+CD8+ T lymphocytes, resulting in a predominance of this cell population in the inflamed heart, central nervous system and skeletal muscle. The VLA-4+-invading cells are surrounded by a fine network of fibronectin that could contribute to cell anchorage, activation and effector functions. Since persistent "danger signals" triggered by the parasite and its antigens are required for the establishment of inflammation and ECM alterations, therapeutic interventions that control parasitism and selectively modulate cell migration improve ECM abnormalities, paving the way for the development of new therapeutic strategies improving the prognosis of T. cruzi-infected individuals.
多条证据表明,克氏锥虫与宿主细胞外基质(ECM)成分相互作用,产生在寄生虫移动和感染性方面起重要作用的分解产物。寄生虫释放的抗原还可调节ECM的表达,这可能参与细胞间和/或细胞与寄生虫的相互作用。在慢性恰加斯病患者的心脏组织以及包括实验性感染克氏锥虫的小鼠的心脏、胸腺、中枢神经系统和骨骼肌在内的多种靶组织中,均已发现ECM成分表达增加。ECM成分可能吸附寄生虫抗原和细胞因子,这可能有助于炎症的发生和持续。此外,感染克氏锥虫的哺乳动物细胞会产生细胞因子和趋化因子,它们不仅参与寄生虫感染的控制,还会促使在多个靶组织中形成慢性炎症病变,并且最常导致严重的心肌炎。克氏锥虫驱动产生的细胞因子和趋化因子还可能调节靶组织内皮细胞上的血管细胞黏附分子-1(VCAM-1)和细胞间黏附分子-1(ICAM-1),在细胞募集尤其是活化的晚期抗原-4(VLA-4)⁺淋巴细胞功能相关抗原-1(LFA-1)⁺CD8⁺T淋巴细胞募集中起关键作用,导致该细胞群体在发炎的心脏、中枢神经系统和骨骼肌中占主导地位。侵入的VLA-4⁺细胞被纤连蛋白的精细网络所包围,这可能有助于细胞锚定、活化和发挥效应功能。由于寄生虫及其抗原引发的持续“危险信号”是炎症和ECM改变发生所必需的,因此控制寄生虫感染并选择性调节细胞迁移的治疗干预措施可改善ECM异常,为开发改善克氏锥虫感染个体预后的新治疗策略铺平了道路。